Item Code: 1013
Quantity: 1 fl. oz. (29.57 ml) 720 drops per bottle
Description: Vitamin D Microemulsified for complete uptake and absorption (in the form of cholecalciferol) 1,000 IU per drop extracted from Lamb's wool. NO PRESERVATIVES!
A study using our product at 2,000 IU daily for 6 weeks achieved an average increase of 202% in serum 25 (OH) vitamin D levels. (see PDF attached)
Vasquez, DC ND DO on: Vitamin D3 contra autoimmunity
Vasquez, DC ND NO on: Vitamin D3 Deficiency controversy
Video: Brain Inflammation
Vitamin D and Autism Study
Vitamin D Concentrations 40 ng ml (4000IU's) Are Associated with 65 Lower Cancer Risk
Interesting Genomic Information
vitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus
Evaluating Vitamin D Levels ~ Dr. Alex Vasquez DC ND DO
- Vitamin D Receptor FokI polymorphism is important in oxalate metabolism due to the binding of oxalate to calcium in the kidney. VDR is required for removal of calcium from the kidneys, driving it into the bones via activation of 1,25 hydroxyvitamin D. The FokI polymorphism of VDR reduces the efficacy of calcium removal from the kidneys, thereby allowing more calcium oxalate formation to occur.
Indications: Consider Hypovitaminosis D, osteoporosis, osteoarthritis, parathyroid dysfunction, diastolic hypotension, calcium and magnesium synergist, free radical issues, bone healing, neuromuscular disease, those who avoid sunshine or are house-bound, inflammatory and autoimmune diseases
Ingredients: Each drop supplies:
Vitamin D (in the form of cholecalciferol) 1,000 IU derived for Lamb's wool.
Suggestion: One drop in pure water or on the back of your clean hand, daily, or as directed by your Health Care Practitioner.
Safety: WARNING: For Adult use only, keep out of reach of children. Use only as recommended unless otherwise directed by a healthcare professional. Excessive consumption of vitamin D has been shown to cause serious health problems.
References: Independent research
Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003 Dec;78( 12):1463-70
Al Faraj S, Al Mutairi K. Vitamin D deficiency and chronic low back pain in Saudi Arabia. Spine. 2003 Jan 15;28( 2):177-9
Excerpt from Chapter 16: Vasquez A. Integrative Orthopedics: Concepts, Algorithms, and Therapeutics - The Art of Creating Wellness While Managing Acute and Chronic Musculoskeletal Injuries, 2004.
Yamashita H, Noguchi S, Takatsu K, Koike E, Murakami T, Watanabe S, Uchino S, Yamashita H, Kawamoto H. High prevalence of vitamin D deficiency in Japanese female patients with Graves\' disease. Endocr J. 2001 Feb;48( 1):63-9
Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999 May;69( 5):842-56
Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr. 2001 Feb;73( 2):288-94
Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003 Jan;77( 1):204-10
Bucci LR, Pillors M, Medlin R, Henderson R, Stiles JC, Robol HJ, Sparks WS. Enhanced uptake in humans of coenzyme Q10 from an emulsified form. Third International Congress of Biomedical Gerontology; Acapulco, Mexico: June 1989